ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 147 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $964,224 | -19.8% | 321,408 | +0.0% | 0.00% | – |
| Q2 2023 | $1,201,681 | +15.9% | 321,305 | +3.8% | 0.00% | – |
| Q1 2023 | $1,037,024 | -32.7% | 309,559 | -3.4% | 0.00% | – |
| Q4 2022 | $1,541,826 | -11.7% | 320,546 | +4.5% | 0.00% | – |
| Q3 2022 | $1,746,000 | -8.9% | 306,856 | +13.6% | 0.00% | – |
| Q2 2022 | $1,917,000 | -4.1% | 270,044 | -2.4% | 0.00% | – |
| Q1 2022 | $1,998,000 | -19.6% | 276,726 | -0.4% | 0.00% | – |
| Q4 2021 | $2,484,000 | -72.7% | 277,793 | +7.1% | 0.00% | -100.0% |
| Q3 2021 | $9,090,000 | +115.6% | 259,274 | +32.1% | 0.00% | +100.0% |
| Q2 2021 | $4,216,000 | +54.3% | 196,275 | +343.7% | 0.00% | 0.0% |
| Q1 2021 | $2,732,000 | +77.6% | 44,237 | +20.1% | 0.00% | – |
| Q4 2020 | $1,538,000 | – | 36,819 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |